Sponsored Content
Vienna International Health and Pharmaceutical Industry News
Read the latest headlines about the Viennese and Austrian health and pharmaceuticals industry
ugichem Closes € 2m Financing Round
The Tyrolean biotech company secured funding from two major investors and a research grant from the Austrian Research Promotion Agency.
August 9, 2011
Intercell Is Looking for Financial Investors
The ailing Austrian biotech company is in urgent need of cash. An acquisition, strategic partnerships and a capital increase are being evaluated.
July 19, 2011
Intercell: “We Will Stabilize Our Share Price”
The Austrian biotech company recorded a dramatic drop in its share price. The CEO remains optimistic and promises stabilization.
June 21, 2011
Intercell to Cut Jobs and Research Budget
The share price plunged by more than 30% after the Austrian pharmaceutical company had announced the termination of a vaccine study.
June 8, 2011
Sanochemia Confirms the Turnaround and Returns to Profitability
Sanochemia reports a profit and puts the focus on market expansion. Revenue increased by 20 percent year-on-year.
May 13, 2011
Intercell: Sale Is No Longer Ruled Out
The new CEO of the Austrian pharmaceutical company, Thomas Lingelbach intends to implement a new strategy for the company. A sale is possible.
May 11, 2011
Lingelbach New CEO for Intercell
Intercell announces new management structure: Thomas Lingelbach appointed new CEO; new Supervisory Board members proposed.
May 5, 2011
Intercell starts a confirmatory clinical study using the Vaccine Enhancement
Intercell starts clinical trial in Pandemic Influenza with its Vaccine Enhancement Patch and provides update to the strategic collaboration with GSK on patches
May 4, 2011
Sanochemia: Capital Increase Disappointing
The Austrian pharmaceutical company could not meet its own expectations regarding the capital increase. A strategic investor bailed out.
April 18, 2011
Intercell: Vaccine Development to Suspend
Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710. The share of Intercell crashed seriously.
April 11, 2011
Intercell Announces next Steps of Development for Pseudomonas Vaccine
Today Intercell AG announced that it has agreed with Novartis to advance Intercell's investigational Pseudomonas aeruginosa vaccine into a confirmatory clinical efficacy trial in ventilated ICU (Intensive Care Unit) patients.
April 2, 2011
Record Sales for VAMED AG
The Austrian health care group was able to increase sales and EBIT by 15%. Orders on hand at over € 800m are record high.
March 25, 2011 · Updated: March 25, 2011; 03:24
Lannacher has Delivery Problems with Iodine Tablets
The Austrian pharmaceutical company manufactures the only potassium iodide tablets in the German-speaking area. Demand strongly exceeds production capacity.
March 18, 2011
Opportunities for Austrian Medical Technology in the UK
An Austrian study showed Austrian buinesses the opportunities offered by the British market: Austrian exports increased by 15% in 2010.
March 17, 2011
Massive Losses for Intercell
The Austrian pharmaceutical company today reported losses for 2010 amounting to € 255m. Operating cash flow has been strongly negative too.
March 2, 2011
Intercell Issues Convertible Bond
The Austrian pharmaceutical company Intercell starts offering of € 30.8m senior convertible debt financing.
February 23, 2011
Sanochemia: Strong Increase in EBIT
The Austrian pharmaceutical company today announced its figures for Q1. Earnings rise eight-fold.
February 18, 2011
Sanochemia Stays in the Red
Despite improvements in its financial data, the Austrian pharmaceutical company Sanochemia does not succeed in eliminating its losses
January 28, 2011
Humanomed to Expand to CEE/SEE
The Austrian Humanomed-Group, a health care company, sees potential to expand to countries in (South) Eastern Europe.
January 28, 2011
Sanochemia Takes Over Alvetra & Werfft
The Austrian pharmaceutical company Sanochemia strengthens its market position through the acquisition of Alvetra & Werfft GmbH.
January 25, 2011
Pfizer Austria: First Sustainability Report Published
Pfizer Austria published its first sustainability report based on the recognized guidelines of the Global Reporting Initiative.
January 20, 2011
Sanochemia: Decrease in Sales, Decrease in Losses
The Vienna Stock Exchange listed manufacturer of pharmaceutical products could improve its results slighty.
January 3, 2011
Intercell Raises Authorized Capital
The Management Board of the Austrian biotechnology company is authorized to increase the share capital up to a nominal amount of € 855,000.00.
December 16, 2010
Serious setback for Intercell
The Vienna vaccine manufacturers has to terminate a research project unexpectedly at a late stage. Heavy losses are expected for this year.
December 14, 2010
Economic Chamber in Tokyo: Biotechnology as an Opportunity
The President of the Vienna Economic Chamber, Brigitte Jank, sees above all great opportunities for Austria in Japanese biotechnology and pharmaceutical industries.
December 6, 2010
Expansion Potential of Austrian Pharmaceutical Industry in Japan
Japanese pharmaceutical companies need new products and international cooperation. An opportunity for local companies.
December 1, 2010
F-Star Acquired Major Order
The Vienna-located f-star and Boehringer Ingelheim to collaborate in discovery and development of therapeutic antibodies.
November 23, 2010
Roche Lays Off 400 Jobs in Styria
The Swiss pharmaceutical group reduces its international workforce by 6%: a setback for the region.
November 18, 2010
Intercell AG: Losses Doubled, Positive Outlook
Today, Vienna-based Intercell AG announced its financial results for the third quarter of 2010 and presented changes to the Management Board.
November 9, 2010
Coface CEE Top 500 - Poland Largest Number of Companies in CEE
Poland has the largest number of companies in the Central and Eastern Europe Top 500 with 28.4%. Hungary ranks second with 16.6%, overtaking the Czech Republic, which is home for 13.8% of the CEE Top 500.
October 12, 2010
Vienna now has its own Expat Center
In Vienna, the first Expat Center in Austria was opened. The project was handled by the Vienna Business Agency (former WWFF).
September 30, 2010
Humanomed Takes Over Management of Private Clinics in the CEE Region
The know-how of the private clinic operator is to be exported. The objective is not to only give advice, but also to take over the management of private clinics in the CEE region.
September 28, 2010
Insolvencies: Declining Trend for Both Companies and Individuals
KSV expects 10% less insolvencies for 2010, but warns about the consequences of fiscal budget adjustment.
September 28, 2010
Austria Continues Being the Largest Investor in Romania
"Romania is an important market in Eastern Europe for the Austrian economy. Its great importance for us is proved by the fact that Austria is by far the largest investor in Romania"
September 23, 2010
Austria's Management and Supervisory Boards’ Salaries on the Test Bench
The partly state-run OMV had the most expensive board of all Austrian corporations in 2009. In total, the oil company spent 10.2 million euro on its bosses, 23.4% more than the previous year.
September 20, 2010
Intercell reports Phase II Study Results of its Vaccine Enhancement Patch for Pandemic Influenza
Intercell AG today announced the results of a Phase II clinical trial of its investigational Vaccine Enhancement Patch (VEP) system for avian H5N1 influenza.
July 2, 2010
Siemens Austria wins award for research project
The research project Reconcile was awarded as best proposal for the funding program FIT-IT (Tesearch, Innovation, technology, information technology) in the program series "Semantic Systems and Services".
June 23, 2010
Wolfgang Hesoun is new head of Siemens - Porr boss succeeds Brigitte Ederer
On Wednesday the Supervisory Board of Siemens Austria will decide on the new head of the company.
June 15, 2010
Siemens VAI Expands in China and India
Upper Austrian Siemens VAI wants to radically expand its activities in China and India.
May 25, 2010
Intercell AG - Hospital bug vaccine delayed
According to an announcement by Zoe Schneeweiss and Namoi Kresge (Bloomberg) Intercell AG fell the most in two weeks in Vienna, after stating that a vaccine against a deadly hospital bug may be delayed to the first or second quarter of 2011.
May 18, 2010
Austrian health insurance sector recorded a small deficit
After last year’s surplus Austria’s 19 health insurance companies are expecting a minor deficit in 2010. According to May’s forecast a €11.8m decline is expected at an overall budget of 14.5 billion euros.
May 17, 2010
Fast News Search
This category only
